- Report
- November 2025
Global
From €6810EUR$7,500USD£5,838GBP
- Report
- October 2025
- 85 Pages
Global
From €4086EUR$4,500USD£3,503GBP
- Report
- August 2025
- 200 Pages
United States
From €2261EUR$2,490USD£1,938GBP
- Report
- August 2025
- 200 Pages
United States
From €2261EUR$2,490USD£1,938GBP
- Report
- February 2026
- 150 Pages
United States
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- November 2025
- 111 Pages
Europe
From €2951EUR$3,250USD£2,530GBP
- Report
- November 2025
- 101 Pages
Asia Pacific
From €2951EUR$3,250USD£2,530GBP
- Report
- November 2025
- 60 Pages
United States
From €2315EUR$2,550USD£1,985GBP
- Report
- November 2025
- 60 Pages
United States
From €2315EUR$2,550USD£1,985GBP
- Report
- November 2025
- 110 Pages
North America
From €2951EUR$3,250USD£2,530GBP
- Report
- November 2025
- 140 Pages
Europe
From €2951EUR$3,250USD£2,530GBP
- Report
- October 2025
- 90 Pages
North America
From €2951EUR$3,250USD£2,530GBP
- Report
- February 2026
- 109 Pages
North America
From €5443EUR$5,995USD£4,666GBP
- Report
- February 2026
- 117 Pages
Europe
From €5443EUR$5,995USD£4,666GBP
- Report
- February 2026
- 117 Pages
Asia Pacific
From €5443EUR$5,995USD£4,666GBP
- Report
- January 2026
- 79 Pages
Africa, Middle East
From €3133EUR$3,450USD£2,685GBP
- Report
- January 2026
- 92 Pages
Asia Pacific
From €3586EUR$3,950USD£3,074GBP
- Report
- January 2026
- 96 Pages
Europe
From €3586EUR$3,950USD£3,074GBP
- Report
- January 2026
- 86 Pages
North America
From €3133EUR$3,450USD£2,685GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4086EUR$4,500USD£3,503GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more